Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$42.5B |
| 2 |
NVIDIA
NVDA
|
+$2.39B |
| 3 |
Walmart Inc
WMT
|
+$1.17B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 5 |
JPMorgan Chase
JPM
|
+$808M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.26B |
| 2 |
Amazon
AMZN
|
+$843M |
| 3 |
Xcel Energy
XEL
|
+$674M |
| 4 |
Global Payments
GPN
|
+$623M |
| 5 |
Palantir
PLTR
|
+$577M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.11% |
| 2 | Financials | 7.1% |
| 3 | Communication Services | 5.53% |
| 4 | Consumer Discretionary | 5.34% |
| 5 | Healthcare | 4.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4476
AllianzIM U.S. Equity 6 Month Buffer10 Feb/Aug ETF
SIXF
$46.1M
| $23.1K | ﹤0.01% |
736
-3,159
| -81% | -$101K |
|
4477
UBS Group
UBS
$170B
| $23.1K | ﹤0.01% |
591
+450
| +319% | +$19.3K |
|
4478
Northern Technologies International Corp
NTIC
$76.4M
| $23.1K | ﹤0.01% |
2,799
-1
| -0% | -$9 |
|
4479
Takeda Pharmaceutical
TAK
$55.1B
| $23K | ﹤0.01% |
1,241
-10,896
| -90% | -$191K |
|
4480
TriSalus Life Sciences
TLSI
$259M
| $23K | ﹤0.01% |
5,741
-41,958
| -88% | -$205K |
|
4481
Gaotu Techedu
GOTU
$372M
| $22.7K | ﹤0.01% |
11,584
+2,018
| +21% | +$4.42K |
|
|
GME.WS
4482
PUT
GameStop Corp Warrants
GME.WS
| $22.6K | ﹤0.01% |
5,860
| – | – |
|
|
SLSN
4483
Solesence Inc
SLSN
$66.4M
| $22.4K | ﹤0.01% |
23,582
-25,162
| -52% | -$31.8K |
|
|
LPRO
4484
Open Lending Corp
LPRO
$373M
| $22.2K | ﹤0.01% |
17,788
-139,595
| -89% | -$221K |
|
|
ARES.PRB
4485
Ares Management Corp 6.75% Series B Preferred Stock
ARES.PRB
$1.22B
| $22.2K | ﹤0.01% |
614
-34,060
| -98% | -$1.46M |
|
|
XRXDW
4486
Xerox Holdings Corp Warrants
XRXDW
$16M
| $22.1K | ﹤0.01% |
+244,323
| New | +$26.9K |
|
4487
RE/MAX Holdings
RMAX
$200M
| $22K | ﹤0.01% |
3,816
-24,687
| -87% | -$171K |
|
4488
Offerpad Solutions
OPAD
$19M
| $21.8K | ﹤0.01% |
3,334
-1
| -0% | -$10 |
|
|
ACR
4489
ACRES Commercial Realty
ACR
$126M
| $21.8K | ﹤0.01% |
1,129
-8,481
| -88% | -$163K |
|
4490
Journey Medical
DERM
$170M
| $21.7K | ﹤0.01% |
4,622
-17,899
| -79% | -$139K |
|
4491
Patriot National Bancorp
PNBK
$132M
| $21.6K | ﹤0.01% |
16,781
-90,732
| -84% | -$131K |
|
|
TIGR
4492
UP Fintech Holding
TIGR
$845M
| $21.4K | ﹤0.01% |
3,393
+893
| +36% | +$7.27K |
|
|
CMPS
4493
Compass Pathways
CMPS
$1.52B
| $21.4K | ﹤0.01% |
3,863
+3,011
| +353% | +$20.3K |
|
|
SRG
4494
Seritage Growth Properties
SRG
$130M
| $21.3K | ﹤0.01% |
7,575
| – | – |
|
4495
ALX Oncology
ALXO
$273M
| $21.1K | ﹤0.01% |
10,515
| – | – |
|
4496
INmune Bio
INMB
$43.1M
| $21.1K | ﹤0.01% |
18,646
-13,372
| -42% | -$19.1K |
|
|
ZENA
4497
ZenaTech Inc
ZENA
$123M
| $21K | ﹤0.01% |
9,191
-1,972
| -18% | -$5.97K |
|
4498
Atomera
ATOM
$201M
| $20.9K | ﹤0.01% |
5,478
-41,573
| -88% | -$157K |
|
4499
iShares iBonds Dec 2032 Term Corporate ETF
IBDX
$1.7B
| $20.3K | ﹤0.01% |
+805
| New | +$20.5K |
|
4500
Cartesian Therapeutics
RNAC
$232M
| $20.3K | ﹤0.01% |
3,307
-14,344
| -81% | -$102K |
|
Similar funds
Barclays's Q1 2026 Portfolio in Review
As of Q1 2026, Barclays held 5,572 positions worth $416B, down 0.11% from $417B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $19.3B of net new capital in Q1 2026, opening 398 new positions and adding to 1,219 existing holdings. Its largest new stake was Sunbelt Rentals Holdings: 1,528,635 shares worth $99.5M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was Tesla, an estimated $1.26B trimmed.
- Barclays's largest Q1 2026 buy was Sunbelt Rentals Holdings: 1,528,635 shares worth $99.5M.
- Barclays added most to iShares MSCI Emerging Markets ETF in Q1 2026, an estimated $42.5B increase.
- Barclays's biggest Q1 2026 reduction was Tesla, cutting an estimated $1.26B.
- Barclays fully exited CyberArk in Q1 2026, selling an estimated $232M.
- Barclays's ten largest holdings make up 37% of its $416B portfolio in Q1 2026.
- Barclays opened 398 new positions and closed 564 in Q1 2026.
- Barclays's portfolio value fell 0.11% quarter-over-quarter to $416B.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.